Company Search:
Advanced Search
Sponsored Links
Walvax Biotechnology Company Limited Company Snapshot
Walvax Biotechnology Company Limited operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Walvax Biotechnology Company Limited with three other companies in this sector in China: Pulike Biological Engineering Inc (2016 sales of 583.09 million Chinese Renmimbi [US$92.94 million] of which 93% was Veterinary Chemicals), Zhenxing Biopharmaceutical & Chemical Co Ltd (567.44 million Chinese Renmimbi [US$90.44 million] of which 100% was Pharmaceutical Sales), and Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (581.89 million Chinese Renmimbi [US$92.75 million] ).

Sales Analysis. During the year ended December of 2016, sales at Walvax Biotechnology Company Limited were 590.16 million Chinese Renmimbi (US$94.07 million). This is a sharp decrease of 41.3% versus 2015, when the company's sales were 1.01 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 76.2% decline in Vaccine Agency, from 578.92 million Chinese Renmimbi to 137.54 million Chinese Renmimbi. There were also decreases in sales in Autonomous Vaccine (down 16.7% to 222.83 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Medicine Agency (up 6.3% to 122.40 million Chinese Renmimbi) and Sales of Service (up 53.4% to 36.13 million Chinese Renmimbi) and Other Operating Revenue (up 75.2% to 36.36 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Walvax Biotechnology Company Limited
  Stock Performance Chart for Walvax Biotechnology Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 20.01
(Figures in Chinese Renmimbi)
1 Week -4.0%   13 Weeks 4.0%  
4 Weeks 8.8%   52 Weeks 82.4%  
Walvax Biotechnology Company Limited Key Data:
  Ticker: 300142 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 590,160,247
(Year Ending Jan 2017).
Employees: 1,227
  Currency: Chinese Renmimbi Market Cap: 30,764,114,050
  Fiscal Yr Ends: December Shares Outstanding: 1,537,436,984
  Share Type: A Gu Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.